Exelixis Clinical Site #3 is a clinical research site located in Tucson, Arizona, United States 85719.
Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.
Exelixis Clinical Site #3 has participated in 1 clinical trials.
Therapeutic areas: Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Mantle Cell Lymphoma (MCL).
Sponsors: Exelixis.
Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Exelixis Clinical Site #3 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Exelixis Clinical Site #3 has 1 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Mantle Cell Lymphoma (MCL).
Exelixis Clinical Site #3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.